{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"retinal-degeneration-nanophthalmos-glaucoma","columns":[{"gene":"","key":"population-81fcac64383b74ee4e28","label":"Retinal degeneration with nanophthalmos, cystic macular degeneration,and angle closure glaucoma","mondoId":"MONDO:0009978","onsetQualifier":null,"originColumnKey":"MONDO:0009978/OMIM:267760","originalViews":[{"key":"MONDO:0009978/OMIM:267760","label":"Retinal degeneration with nanophthalmos, cystic macular degeneration,and angle closure glaucoma","scopeLabel":"OMIM:267760","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["072e84a5be8554d345f8e857efed0a0001bbb95dff487fbcaa2aba75d61bfa76","259d2c0f86e7e6e0a8e33e6cd5fd5dea6063770deb966dd83e252458bc9003a2","2865c271c70b7324d716cc646a2a904db430df02a8b4de543f989191f9306eb5","397f721f5099f0c0dcd47ee51816e0f9f02a9fd8078173c5034c37427b10bdc8","52b1a228815d5ee80bce204cdf3444694957d8441dd2b2b0ed5cc2cbeb5281ea","7b7009f81366c85c6bcfea2deb94f4c020d4a676a31816784e1a8f12f34263a7","acf92303d8be69a4e1236858dda557612bb5e8d5830d7f5f5a069d3da0c487df","ad6aa1c92c9ce77a3a9f32c7b40376763e069a3ca8082a83f61b35a671d98f8c","e9a9bd309e5a56cfeb7f75032d451dd3584357551ff86b4b4aba5ed5684edd00"],"recordQualifiers":{},"scopeLabel":"OMIM:267760","sourceIds":["OMIM:267760"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-bee42a6ee8e1ad85dad4","label":"Retinal degeneration-nanophthalmos-glaucoma syndrome","mondoId":"MONDO:0009978","onsetQualifier":null,"originColumnKey":"MONDO:0009978/ORPHA:1574","originalViews":[{"key":"MONDO:0009978/ORPHA:1574","label":"Retinal degeneration-nanophthalmos-glaucoma syndrome","scopeLabel":"ORPHA:1574","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["05e15485283e81e127c4ae0b8e9fef12a9b65576cb40bb4b2bc4f8252faf54b9","34fc7b31ca76224b395b2c01c72594253234dc10387ca637f5ebde79bb03033f","99790a47c77eedb2e2d0a6e8d2e140c9e18f1d47f72f0ae552bbb1dad2ad8e11","ba337995268e9a3bc2fc7c8f9646778867375b171d99a3e2d7dfe7372295f9a4","c65f21b25123a6b8fc3296db33d18d287067a14c922c012287ea798a258bc0c8","fb0a03ed20fac0267f678564bab056349c9877a8d0ecc57a32fc8c35ea34c882","fc54326ef64287a53cd5a07ef94ec16c98a136037c0f1860d8a7ba4a21784bd3"],"recordQualifiers":{},"scopeLabel":"ORPHA:1574","sourceIds":["ORPHA:1574"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-81fcac64383b74ee4e28","population-bee42a6ee8e1ad85dad4"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000512","HP:0007703","HP:0001133","HP:0008028","HP:0000501","HP:0000540","HP:0007401"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":16,"sourceGroups":{"omim":2,"orphanet":7,"published":7}},"features":[{"hpoId":"HP:0000512","label":"Abnormal electroretinogram","primary":true},{"hpoId":"HP:0007703","label":"Abnormal retinal pigmentation","primary":true},{"hpoId":"HP:0001133","label":"Constriction of peripheral visual field","primary":true},{"hpoId":"HP:0008028","label":"Cystoid macular degeneration","primary":true},{"hpoId":"HP:0000501","label":"Glaucoma","primary":true},{"hpoId":"HP:0000540","label":"Hypermetropia","primary":true},{"hpoId":"HP:0007401","label":"Macular atrophy","primary":true},{"hpoId":"HP:0000568","label":"Microphthalmia","primary":false},{"hpoId":"HP:0000545","label":"Myopia","primary":false},{"hpoId":"HP:0000662","label":"Nyctalopia","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0000546","label":"Retinal degeneration","primary":false},{"hpoId":"HP:0000594","label":"Shallow anterior chamber","primary":false},{"hpoId":"HP:0000505","label":"Visual impairment","primary":false}],"ledeHtml":"Retinal degeneration-nanophthalmos-glaucoma syndrome is characterized by progressive pigmentary retinal degeneration (with nyctalopia and visual field restriction), cystic macular degeneration and angle closure glaucoma. It has been described in seven members of one family. Patients also have hyperopia and nanophthalmos. The mode of transmission is autosomal recessive.","mondoId":"MONDO:0009978","node":{"canonicalSlug":"retinal-degeneration-nanophthalmos-glaucoma","comparisons":[{"documentSha256":"d8a26694f5dbda011f0ed9c1ad3e59e377ed8971b184840ca47a163ecc53e5c0","key":"legacy-retinal-degeneration-nanophthalmos-glaucoma","kind":"legacy","label":"retinal degeneration-nanophthalmos-glaucoma syndrome","memberIds":["MONDO:0009978"],"mondoId":"MONDO:0009978","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/retinal-degeneration-nanophthalmos-glaucoma.d8a26694f5dbda011f0ed9c1ad3e59e377ed8971b184840ca47a163ecc53e5c0.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Retinal degeneration-nanophthalmos-glaucoma syndrome","originalSourceId":"ORPHA:1574","paragraphs":["Retinal degeneration-nanophthalmos-glaucoma syndrome is characterized by progressive pigmentary retinal degeneration (with nyctalopia and visual field restriction), cystic macular degeneration and angle closure glaucoma. It has been described in seven members of one family. Patients also have hyperopia and nanophthalmos. The mode of transmission is autosomal recessive."],"rawAttribution":"MONDO:0009978","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:04:45Z","upstream":"MONDO:0009978","url":"https://rarediseases.info.nih.gov/diseases/395"},"ownColumnKeys":["population-81fcac64383b74ee4e28","population-bee42a6ee8e1ad85dad4"],"publication":"published","relationships":[{"kind":"parent","label":"inherited retinal dystrophy","mondoId":"MONDO:0019118","slug":"inherited-retinal-dystrophy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"05e15485283e81e127c4ae0b8e9fef12a9b65576cb40bb4b2bc4f8252faf54b9","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1574","disease_name":"Retinal degeneration-nanophthalmos-glaucoma syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"ORPHA:1574","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"072e84a5be8554d345f8e857efed0a0001bbb95dff487fbcaa2aba75d61bfa76","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:267760","disease_name":"Retinal degeneration with nanophthalmos, cystic macular degeneration,and angle closure glaucoma","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0008028","is_excluded":false,"label":"Cystoid macular degeneration","onset_id":null,"reference":"OMIM:267760","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"259d2c0f86e7e6e0a8e33e6cd5fd5dea6063770deb966dd83e252458bc9003a2","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:267760","disease_name":"Retinal degeneration with nanophthalmos, cystic macular degeneration,and angle closure glaucoma","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000540","is_excluded":false,"label":"Hypermetropia","onset_id":null,"reference":"PMID:3827713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"2865c271c70b7324d716cc646a2a904db430df02a8b4de543f989191f9306eb5","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:267760","disease_name":"Retinal degeneration with nanophthalmos, cystic macular degeneration,and angle closure glaucoma","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000594","is_excluded":false,"label":"Shallow anterior chamber","onset_id":"HP:0011463","reference":"PMID:3827713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"34fc7b31ca76224b395b2c01c72594253234dc10387ca637f5ebde79bb03033f","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1574","disease_name":"Retinal degeneration-nanophthalmos-glaucoma syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000512","is_excluded":false,"label":"Abnormal electroretinogram","onset_id":null,"reference":"ORPHA:1574","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"397f721f5099f0c0dcd47ee51816e0f9f02a9fd8078173c5034c37427b10bdc8","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:267760","disease_name":"Retinal degeneration with nanophthalmos, cystic macular degeneration,and angle closure glaucoma","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000662","is_excluded":false,"label":"Nyctalopia","onset_id":null,"reference":"PMID:3827713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"52b1a228815d5ee80bce204cdf3444694957d8441dd2b2b0ed5cc2cbeb5281ea","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:267760","disease_name":"Retinal degeneration with nanophthalmos, cystic macular degeneration,and angle closure glaucoma","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001133","is_excluded":false,"label":"Constriction of peripheral visual field","onset_id":null,"reference":"PMID:3827713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7b7009f81366c85c6bcfea2deb94f4c020d4a676a31816784e1a8f12f34263a7","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:267760","disease_name":"Retinal degeneration with nanophthalmos, cystic macular degeneration,and angle closure glaucoma","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000546","is_excluded":false,"label":"Retinal degeneration","onset_id":null,"reference":"PMID:3827713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"99790a47c77eedb2e2d0a6e8d2e140c9e18f1d47f72f0ae552bbb1dad2ad8e11","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1574","disease_name":"Retinal degeneration-nanophthalmos-glaucoma syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000545","is_excluded":false,"label":"Myopia","onset_id":null,"reference":"ORPHA:1574","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"acf92303d8be69a4e1236858dda557612bb5e8d5830d7f5f5a069d3da0c487df","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:267760","disease_name":"Retinal degeneration with nanophthalmos, cystic macular degeneration,and angle closure glaucoma","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000568","is_excluded":false,"label":"Microphthalmia","onset_id":null,"reference":"PMID:3827713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ad6aa1c92c9ce77a3a9f32c7b40376763e069a3ca8082a83f61b35a671d98f8c","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:267760","disease_name":"Retinal degeneration with nanophthalmos, cystic macular degeneration,and angle closure glaucoma","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000501","is_excluded":false,"label":"Glaucoma","onset_id":null,"reference":"OMIM:267760","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"ba337995268e9a3bc2fc7c8f9646778867375b171d99a3e2d7dfe7372295f9a4","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1574","disease_name":"Retinal degeneration-nanophthalmos-glaucoma syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"ORPHA:1574","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c65f21b25123a6b8fc3296db33d18d287067a14c922c012287ea798a258bc0c8","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1574","disease_name":"Retinal degeneration-nanophthalmos-glaucoma syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"ORPHA:1574","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e9a9bd309e5a56cfeb7f75032d451dd3584357551ff86b4b4aba5ed5684edd00","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:267760","disease_name":"Retinal degeneration with nanophthalmos, cystic macular degeneration,and angle closure glaucoma","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0007401","is_excluded":false,"label":"Macular atrophy","onset_id":"HP:0003581","reference":"PMID:3827713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"fb0a03ed20fac0267f678564bab056349c9877a8d0ecc57a32fc8c35ea34c882","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1574","disease_name":"Retinal degeneration-nanophthalmos-glaucoma syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007703","is_excluded":false,"label":"Abnormal retinal pigmentation","onset_id":null,"reference":"ORPHA:1574","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fc54326ef64287a53cd5a07ef94ec16c98a136037c0f1860d8a7ba4a21784bd3","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1574","disease_name":"Retinal degeneration-nanophthalmos-glaucoma syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000568","is_excluded":false,"label":"Microphthalmia","onset_id":null,"reference":"ORPHA:1574","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/395\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009978\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0009978</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Retinal degeneration-nanophthalmos-glaucoma syndrome is characterized by progressive pigmentary retinal degeneration (with nyctalopia and visual field restriction), cystic macular degeneration and angle closure glaucoma. It has been described in seven members of one family. Patients also have hyperopia and nanophthalmos. The mode of transmission is autosomal recessive.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/395\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"retinal-degeneration-nanophthalmos-glaucoma","sourceDocuments":[{"name":"GARD: Retinal degeneration-nanophthalmos-glaucoma syndrome","reviewed":null,"source_release":"2026-10-21T17:04:45Z","url":"https://rarediseases.info.nih.gov/diseases/395"},{"name":"MONDO: retinal degeneration-nanophthalmos-glaucoma syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009978"}],"sourceNote":"","synonyms":["MacKay Shek Carr syndrome","Mackay-Shek-Carr syndrome","retinal degeneration, nanophthalmos, glaucoma"],"takeawayHtml":"","title":"retinal degeneration-nanophthalmos-glaucoma syndrome"},"schemaVersion":1}
